Xenetic Biosciences (XBIO)
(Delayed Data from NSDQ)
$3.80 USD
-0.12 (-3.06%)
Updated May 14, 2024 10:47 AM ET
After-Market: $3.84 +0.04 (1.05%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/09/2024
Time: -- |
6/2024 | $-0.83 | 0.00% |
Earnings Summary
For their last quarter, Xenetic Biosciences (XBIO) reported earnings of -$0.78 per share, beating the Zacks Consensus Estimate of $-0.79 per share. This reflects a positive earnings surprise of 1.27%. Look out for XBIO's next earnings release expected on August 09, 2024. For the next earning release, we expect the company to report earnings of -$0.83 per share, reflecting a year-over-year decrease of 20.29%.
Earnings History
Price & Consensus
Zacks News for XBIO
Xenetic Biosciences (XBIO) Reports Q2 Loss, Tops Revenue Estimates
XBIO: What are Zacks experts saying now?
Zacks Private Portfolio Services